Does pioglitazone provide a better renoprotective effect than insulin in diabetic patients?

Kidney Int. 2008 Oct;74(7):970-1; author reply 971. doi: 10.1038/ki.2008.371.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Animals
  • Diabetes Mellitus / drug therapy*
  • Humans
  • Insulin / therapeutic use*
  • Kidney / drug effects
  • Pioglitazone
  • Protective Agents
  • Rats
  • Thiazolidinediones / therapeutic use*

Substances

  • Insulin
  • Protective Agents
  • Thiazolidinediones
  • Pioglitazone